ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

RGT Argent Biopharma Limited

21.00
0.00 (0.00%)
25 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Argent Biopharma Limited LSE:RGT London Ordinary Share AU0000326647 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 21.00 20.00 22.00 21.00 21.00 21.00 7,884 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Argent Biopharma Share Discussion Threads

Showing 58201 to 58218 of 58275 messages
Chat Pages: 2331  2330  2329  2328  2327  2326  2325  2324  2323  2322  2321  2320  Older
DateSubjectAuthorDiscuss
12/11/2014
18:51
Not really, Doorway - a different one almost every day. :) I'm quite well thanks, Stav. How about you?
asmodeus
16/10/2014
18:37
Thanks ASMO, hope you are well.
stav5001
04/10/2014
21:53
Accounts to end year 2013.

Sales of Col down from 246k to 179k. Directors took no fees. Last 40k of loan drawn down on 17th May. Tiziana " will convert this loan to RGTL shares "at an appropriate time" Indian distributor "lost". Metagenics introduced a Col. combination product in Summer 2014, but have not revealed how well it was received (!) Etc. Etc. Groan.

asmodeus
17/3/2014
18:46
Apparently Dec 2012 accounts out today. Edit - have looked at "Companies in the UK", and it seems it is only "a full list of Directors and Shareholders" that has been published today NOT the Company Accounts.
asmodeus
11/2/2013
03:46
. . .I endorse that remark.


...oh, and regarding cubeboss, it's, ;0)))))))))))0)))))0));0))))))))))))))))))))))))))))))))))))

lean5gb3
08/2/2013
09:46
After 10 yrs of buying into this *&%*%*%..... what i thought was an investment.... any change , any news.. or still the same old " this will be our year" !!! back into my hole.. see ya in 10 more years.. !! where's that cubeboss and his .....!!!!!!^^^^ $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
mrdavies
01/8/2012
08:47
I did as it was so obvious...so many broken promises.
danielmiller1
31/7/2012
17:26
DanielMiller1 31 Jul'12 - 13:56 - 57881 of 57881
you were warned at the time of the consolidation that there was only one way to go



Daniel
a. anyone saying that at the time didnt know what they were saying
b. it is far from over

the_doctor
31/7/2012
13:56
you were warned at the time of the consolidation that there was only one way to go and that was down...you were happy to give out stick at the time, like shoot the messenger but I oite that you cant take it now.


STAV5001
30 Jul'12 - 08:26 - 57880 of 57880

I take the same attitude as the market and market makers take with me!

Also I just cant stomach stupidity!

danielmiller1
30/7/2012
08:26
Daniel

Someone said "Never look down on anyone, unless you are giving them a hand up"

stav5001
18/7/2012
22:25
So you will go to bed happy, then, confident in the satisfaction of knowing how right you were,(so far) and gloating over how much money we have lost. Many thanks.
asmodeus
18/7/2012
18:43
oh yes there were, mine right until about two years ago from the stock consolidation and before.
danielmiller1
18/7/2012
12:29
SUCKERS ONE AND ALL YET READ BACK THERE WERE SUFFICIENT WARNINGS GIVEN
danielmiller1
11/2/2012
22:44
So - have metagenics made any mention of Colostrinin, or products containing it?
asmodeus
11/2/2012
22:14
Wassssuuuuupppp people?
runtus
03/10/2011
06:34
CSO of Metagenics to host workshop on breakthrough medical foods

October 2, 2011 - Jeffrey Bland, PhD, FACN, CNS, chief science officer for Metagenics Inc., a nutrigenomics and lifestyle medicine company dedicated to reducing chronic illness and improving health, will host a presentation on medical foods on Oct. 26 at the World Health Forum at Harvard Medical School in Boston.

"Research is demonstrating that the value of medical foods to our healthcare system is enormous," said Bland. "Metagenics' medical foods are developed through nutrigenomics - the science of how food affects our genetic expression - which are a safe, effective way to fight the epidemic of chronic illness that is currently occurring worldwide."

The cost of these chronic illnesses in the United States alone is estimated to be $1.5 trillion annually, according to the Centers for Disease Control and Prevention.

Medical foods, a category recognized by the U.S. Federal Drug Administration (FDA), can be viewed as "therapeutic nutrition." They are formulated and intended for the specific dietary management of a disease or condition. Metagenics-sponsored research has proven that patients who incorporate a medical food into their diets, as well as make necessary lifestyle changes, can improve their health quickly and safely.

Recently, the Journal of Clinical Lipidology reported results of a 12 week multi-center clinical trial conducted by the University of Connecticut, University of Florida, and the

University of California, Irvine that showed Metagenics' UltraMeal PLUS 360° medical food and a low-glycemic Mediterranean diet is almost twice as likely to lower certain cardiovascular risk factors as this same diet alone, and is 40 percent more likely to resolve the effects of metabolic syndrome.

The medical foods workshop will cover:

•"The Concept of Medical Foods and their Regulatory Framework," presented by Dr. Jeffrey Bland.
•"The Medical Foods Business Environment," moderated by Willy Pardiñas, Senior Vice President and General Manager, Americas at Metagenics.
•"Clinical Applications of Medical Foods," moderated by Robert Lerman, MD, Ph.D., Director of Medicine and Extramural Clinical Research at Metagenics.
•"Food-derived Bioactives and the Composition of Medical Foods," moderated by Matthew Tripp, PhD, Senior Vice President of Research and Development at Metagenics.
Objectives of the workshop are:

•To describe the medical foods category, how it is mandated and regulated.
•To define the clinical value and application of medical foods.
•To understand the bioactive ingredients and their influence related to the nutritional requirements of specific diseases.
•To better understand the medical foods commercial space.
For the agenda, registration and more information on World Health Forum at Harvard Medical School, visit www.bostonworldhealthforum.com.

share_shark
28/9/2011
00:57
agree ::CLN should also have been promoted as an ideal health booster, but nothing there from the old BOD.
genises
20/9/2011
10:27
...spot on daniel.......The BOD's were far too comatosed to market cln in the most efficient way, and now sales are suffering as a consequence, as technology is slowly but surely getting there as regards treating alzhiemers. CLN should also have been promoted as an ideal health booster, but nothing there from the BOD's neither. .....anyway




...'upwards and onwards'(sigh)


...'more beer wife !'..btw darling, is my hair thicker and darker?

lean5gb
Chat Pages: 2331  2330  2329  2328  2327  2326  2325  2324  2323  2322  2321  2320  Older

Your Recent History

Delayed Upgrade Clock